
Please try another search
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Andrew H. Sassine | 57 | 2018 | CFO & Director |
Karah Herdman Parschauer | 43 | 2019 | Director |
Joseph E. Payne | 49 | 2013 | Founder, President, CEO & Director |
Magda Marquet | 65 | 2018 | Independent Director |
Michael R. Hodges | - | 2014 | Member of Scientific Advisory Board |
Drew Weissman | - | 2015 | Member of Scientific Advisory Board |
James F. Barlow | 64 | 2018 | Independent Director |
Edward W. Holmes | 82 | 2019 | Independent Director |
Peter C. Farrell | 83 | 2018 | Independent Director |
Steven George Hughes | 57 | 2022 | Strategic Clinical Advisor & Member of Scientific Advisory Board |
Frederick G. Hayden | - | 2020 | Member of the Vaccine Platform Scientific Advisory Board |
Robert T. Schooley | - | 2020 | Member of the Vaccine Platform Scientific Advisory Board |
Jing L. Marantz | 60 | 2021 | Independent Director |
John H. Markels | 58 | 2022 | Independent Director |
Jonathan F. Smith | - | 2020 | Member of the Vaccine Platform Scientific Advisory Board |
Peter A. Patriarca | - | 2020 | Member of the Vaccine Platform Scientific Advisory Board |
Eng Eong Ooi | - | 2020 | Member of the Vaccine Platform Scientific Advisory Board |
Moncef M. Slaoui | 66 | 2024 | Independent Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review